• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠期糖尿病筛查:美国预防服务工作组的系统评价。

Screening tests for gestational diabetes: a systematic review for the U.S. Preventive Services Task Force.

机构信息

University of Calgary, Calgary, Canada.

出版信息

Ann Intern Med. 2013 Jul 16;159(2):115-22. doi: 10.7326/0003-4819-159-2-201307160-00657.

DOI:10.7326/0003-4819-159-2-201307160-00657
PMID:23712349
Abstract

BACKGROUND

A 50-g oral glucose challenge test (OGCT) is a widely accepted screening method for gestational diabetes mellitus (GDM), but other options are being considered.

PURPOSE

To systematically review the test characteristics of various screening methods for GDM across a range of recommended diagnostic glucose thresholds.

DATA SOURCES

15 electronic databases from 1995 to May 2012, reference lists, Web sites of relevant organizations, and gray literature.

STUDY SELECTION

Two reviewers independently identified English-language prospective studies that compared any screening test for GDM with any reference standard.

DATA EXTRACTION

One reviewer extracted and a second reviewer verified data from 51 cohort studies. Two reviewers independently assessed methodological quality.

DATA SYNTHESIS

The sensitivity, specificity, and positive and negative likelihood ratios for the OGCT at a threshold of 7.8 mmol/L (140 mg/dL) were 70% to 88%, 69% to 89%, 2.6 to 6.5, and 0.16 to 0.33, respectively. At a threshold of 7.2 mmol/L (130 mg/dL), the test characteristics were 88% to 99%, 66% to 77%, 2.7 to 4.2, and 0.02 to 0.14, respectively. For a fasting plasma glucose threshold of 4.7 mmol/L (85 mg/dL), they were 87%, 52%, 1.8, and 0.25, respectively. Glycated hemoglobin level had poorer test characteristics than fasting plasma glucose level or the OGCT. No studies compared the OGCT with International Association of the Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria.

LIMITATIONS

The lack of a gold standard for confirming GDM limits comparisons. Few data exist for screening tests before 24 weeks' gestation.

CONCLUSION

The OGCT and fasting plasma glucose level (at a threshold of 4.7 mmol/L [85 mg/dL]) by 24 weeks' gestation are good at identifying women who do not have GDM. The OGCT is better at identifying women who have GDM. The OGCT has not been validated for the IADPSG diagnostic criteria.

摘要

背景

50 克口服葡萄糖挑战试验(OGCT)是一种广泛接受的妊娠期糖尿病(GDM)筛查方法,但也有其他方法正在考虑中。

目的

系统综述不同筛查方法在各种推荐诊断血糖阈值下对 GDM 的检测特性。

数据来源

1995 年至 2012 年 5 月的 15 个电子数据库、参考文献列表、相关组织的网站和灰色文献。

研究选择

两名审查员独立确定了比较任何 GDM 筛查试验与任何参考标准的英语前瞻性研究。

数据提取

一名审查员提取数据,另一名审查员对 51 项队列研究的数据进行验证。两名审查员独立评估方法学质量。

数据综合

OGCT 在阈值为 7.8mmol/L(140mg/dL)时的敏感性、特异性、阳性和阴性似然比分别为 70%至 88%、69%至 89%、2.6 至 6.5 和 0.16 至 0.33;在阈值为 7.2mmol/L(130mg/dL)时,这些指标分别为 88%至 99%、66%至 77%、2.7 至 4.2 和 0.02 至 0.14;在空腹血糖阈值为 4.7mmol/L(85mg/dL)时,这些指标分别为 87%、52%、1.8 和 0.25。糖化血红蛋白水平的检测特性比空腹血糖水平或 OGCT 差。没有研究比较 OGCT 与国际妊娠糖尿病协会和妊娠协会(IADPSG)诊断标准。

局限性

缺乏 GDM 确诊的金标准,限制了比较。24 周前妊娠的筛查试验数据较少。

结论

OGCT 和 24 周前空腹血糖水平(阈值为 4.7mmol/L[85mg/dL])对识别未患 GDM 的女性较为准确。OGCT 对识别患有 GDM 的女性更准确。OGCT 尚未通过 IADPSG 诊断标准验证。

相似文献

1
Screening tests for gestational diabetes: a systematic review for the U.S. Preventive Services Task Force.妊娠期糖尿病筛查:美国预防服务工作组的系统评价。
Ann Intern Med. 2013 Jul 16;159(2):115-22. doi: 10.7326/0003-4819-159-2-201307160-00657.
2
Different intensities of glycaemic control for women with gestational diabetes mellitus.妊娠期糖尿病女性不同强度的血糖控制
Cochrane Database Syst Rev. 2016 Apr 7;4(4):CD011624. doi: 10.1002/14651858.CD011624.pub2.
3
Different strategies for diagnosing gestational diabetes to improve maternal and infant health.诊断妊娠期糖尿病以改善母婴健康的不同策略。
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD007122. doi: 10.1002/14651858.CD007122.pub4.
4
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee.妊娠期高血糖筛查:国家筛查委员会快速更新。
Health Technol Assess. 2010 Sep;14(45):1-183. doi: 10.3310/hta14450.
5
Different intensities of glycaemic control for women with gestational diabetes mellitus.不同强度的血糖控制对妊娠期糖尿病妇女的影响。
Cochrane Database Syst Rev. 2023 Oct 10;10(10):CD011624. doi: 10.1002/14651858.CD011624.pub3.
6
Screening for gestational diabetes mellitus based on different risk profiles and settings for improving maternal and infant health.基于不同风险特征和环境进行妊娠期糖尿病筛查以改善母婴健康。
Cochrane Database Syst Rev. 2017 Aug 3;8(8):CD007222. doi: 10.1002/14651858.CD007222.pub4.
7
The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation.孕期高血糖女性的识别与治疗:个体参与者数据、系统评价、荟萃分析及经济评估
Health Technol Assess. 2016 Nov;20(86):1-348. doi: 10.3310/hta20860.
8
Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis.高血糖与围产期不良结局风险:系统评价与荟萃分析
BMJ. 2016 Sep 13;354:i4694. doi: 10.1136/bmj.i4694.
9
Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.孕前患有糖尿病的女性孕期血糖监测技术。
Cochrane Database Syst Rev. 2017 Jun 11;6(6):CD009613. doi: 10.1002/14651858.CD009613.pub3.
10
Screening for gestational diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force.妊娠期糖尿病的筛查:美国预防服务工作组的一项系统评价
Ann Intern Med. 2008 May 20;148(10):766-75. doi: 10.7326/0003-4819-148-10-200805200-00009.

引用本文的文献

1
Increasing Risk of Gestational Diabetes in an Ethnocultural Minority of Canada.加拿大一个少数族裔群体中妊娠期糖尿病风险增加。
J Immigr Minor Health. 2025 Apr;27(2):191-199. doi: 10.1007/s10903-024-01667-6. Epub 2025 Jan 17.
2
Design, rationale and protocol for Glycemic Observation and Metabolic Outcomes in Mothers and Offspring (GO MOMs): an observational cohort study.《血糖观察与母婴代谢结局研究(GO MOMs):一项观察性队列研究》的设计、原理和方案。
BMJ Open. 2024 Jun 8;14(6):e084216. doi: 10.1136/bmjopen-2024-084216.
3
Effectiveness of Glycated Haemoglobin in the Diagnosis of Gestational Diabetes Mellitus among Pregnant Women in Port Harcourt, Nigeria.
糖化血红蛋白在尼日利亚哈科特港孕妇妊娠期糖尿病诊断中的有效性
Niger Med J. 2022 Apr 28;62(4):171-177. doi: 10.60787/NMJ-62-4-31. eCollection 2021 Jul-Aug.
4
An Automated Online Measure for Misophonia: The .一种用于恐声症的自动化在线测量工具:……
Assessment. 2024 Dec;31(8):1598-1614. doi: 10.1177/10731911241234104. Epub 2024 Feb 27.
5
Maternal glucose levels and future risk of developing cardiovascular disease: a systematic review and meta-analysis protocol.母体血糖水平与未来心血管疾病发病风险:系统评价和荟萃分析方案。
BMJ Open. 2023 May 2;13(5):e069251. doi: 10.1136/bmjopen-2022-069251.
6
The frequency of acceptance of oral glucose tolerance test in Turkish pregnant women: A single tertiary center results.土耳其孕妇口服葡萄糖耐量试验的接受频率:单中心三级医院结果
North Clin Istanb. 2022 Apr 13;9(2):140-148. doi: 10.14744/nci.2021.80588. eCollection 2022.
7
Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications.妊娠期糖尿病:诊断方法及母婴并发症。
Diabetes Metab J. 2022 Jan;46(1):3-14. doi: 10.4093/dmj.2021.0335. Epub 2022 Jan 27.
8
Performance of guidelines for the screening and diagnosis of gestational diabetes mellitus during the COVID-19 pandemic: A scoping review of the guidelines and diagnostic studies evaluating the recommended testing strategies.2019年冠状病毒病大流行期间妊娠期糖尿病筛查与诊断指南的执行情况:对评估推荐检测策略的指南及诊断研究的范围综述
Diabet Epidemiol Manag. 2021 Jul-Sep;3:100023. doi: 10.1016/j.deman.2021.100023. Epub 2021 Nov 6.
9
Effectivness of specific mobile health applications (mHealth-apps) in gestational diabtetes mellitus: a systematic review.特定移动医疗应用(mHealth-apps)在妊娠期糖尿病中的有效性:系统评价。
BMC Pregnancy Childbirth. 2021 Dec 5;21(1):808. doi: 10.1186/s12884-021-04274-7.
10
Early markers of gestational diabetes mellitus: what we know and which way forward?妊娠期糖尿病的早期标志物:我们已知晓的和未来的发展方向?
Biochem Med (Zagreb). 2021 Oct 15;31(3):030502. doi: 10.11613/BM.2021.030502.